go back

North Dakota rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $562,341 · 10th–90th $562,341–$1,023,2930%50%90th$562,341Professionalmedian $562,341 · 10th–90th $562,341–$707,9460%50%90th$562,341$500.0K$1.0M$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $1,023,292.99
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$562,341.33 / $562,341.33 / $707,945.78
Cigna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$524,807.46 / $537,031.80 / $676,082.98
Medica
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$537,031.80 / $851,138.04 / $1,819,700.86
Medica
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$977,237.22 / $977,237.22 / $977,237.22
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$616,595.00 / $616,595.00 / $616,595.00
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$407,380.28 / $512,861.38 / $851,138.04